Importantly, such effects were consistent with effective modulation of the prominent markers of dyslipidemia, inflammation, and oxidative stress, including low-density lipoprotein (LDL)-cholesterol, and high sensitivity C-reactive protein (hs-CRP) and plasma GSH levels. Here, CRP is linked to metabolic syndrome.